Patricia Gonzalez

Goal-driven bilingual healthcare professional offering over 19 years of refined clinical and administrative experience, well-versed in study protocols, standard operating procedures, and general trial oversight. Excellent problem-solving abilities with a detail-oriented nature. Efficient and highly adaptive working in fast paced settings with diverse patient populations, physicians and project directors. Authoritative clear communicator that provides operational excellence and organizational development with proven success in leadership that inspires team members to excel in a creative work environment.

• Good Clinical Training 12-17-2020
• NIH Protecting Human Research Participants 01-08-2020
• Transporting Dangerous Goods Training 01-08-2020
• Handling/Offering for transportation of dangerous goods training 01-08-2020
• BLS
• Privacy & HIPPA

A Prospective, Multicenter, Open-label single-arm feasibility study assessing the tolerability of opioid medication reduction in conjunction with noninvasive peripheral nerve stimulation (NPNS) for patients taking prescription opioids to treat moderate-severe primary RLS

A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection (DAXI for Injection) for the Combined Treatment of Upper Facial Lines (Glabellar Lines, Dynamic Forehead Lines and Lateral Canthal Lines)

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficiency and Safety of DR220-67 Anti-Aging Serum in the Treatment of Facial Lines in Women Ages 35-60

A Prospective, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability and Safety of a Nutraceutical Supplement with Standardized Botanicals to Promote Hair Growth in Perimenopausal, Menopausal and Post-Menopausal Women with Self-Perceived Thinning Hair

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa

A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines

A Randomized, No-treatment Controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Defyne in the Chin for Augmentation and Correction of Chin Retrusion

A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea

A Phase 3, Double-Blind, Vehicle-Controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects With Actinic Keratosis on the Face or Scalp

An Open Label, Multi-Center Trial to Assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines (SAKURA OPEN LABEL SAFETY)

Epic, Medidata (RAVE), eCaselink, AG Mednet, Covance, ERT, Inform, Oracle IRT, iMedNet, ICD-9

Microsoft Office, Outlook, Word, Excel, Powerpoint, 365, Windows: Vista, 7, 8, 10, Adobe acrobat